Jan Borovicka

Author PubWeight™ 27.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010 7.86
2 Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J Hepatol 2009 3.28
3 Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol 2008 1.70
4 Diffuse esophageal spasm. Am J Gastroenterol 2007 1.38
5 Functional outcome after perineal stapled prolapse resection for external rectal prolapse. BMC Surg 2010 0.95
6 Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial. Gastrointest Endosc 2002 0.91
7 Relevance of incidental colorectal FDG-PET/CT-enhanced lesions. Onkologie 2013 0.89
8 Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial. Hepatology 2002 0.84
9 Perception of gastrointestinal endoscopy by patients and examiners with and without background music. Digestion 2003 0.83
10 Malignant biliary stenosis: conventional cytology versus DNA image cytometry. Surg Endosc 2010 0.81
11 Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study. Swiss Med Wkly 2010 0.79
12 Altered esophageal motility and gastroesophageal barrier in patients with jejunal interposition after distal esophageal resection for early stage adenocarcinoma. J Gastrointest Surg 2007 0.78
13 Benefit of baseline cytometry for surveillance of patients with Barrett's esophagus. Surg Endosc 2009 0.78
14 Is a barium swallow complementary to endoscopy essential in the preoperative assessment of laparoscopic antireflux and hiatal hernia surgery? Surg Endosc 2007 0.77
15 The influence of postural changes on gastroesophageal reflux and barrier pressure in nonfasting individuals. Anesth Analg 2005 0.77
16 Laparoscopic Mesh-augmented Hiatoplasty With Cardiophrenicopexy Versus Laparoscopic Nissen Fundoplication for the Treatment of Gastroesophageal Reflux Disease: A Double-center Randomized Controlled Trial. Ann Surg 2015 0.77
17 Efficacy of laparoscopic mesh-augmented hiatoplasty in GERD and symptomatic hiatal hernia. Study using combined impedance-pH monitoring. J Gastrointest Surg 2008 0.76
18 Twenty-four vs. forty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in interferon alpha monotherapy relapsers with chronic hepatitis C. Swiss Med Wkly 2003 0.76
19 Preoperative administration of esomeprazole has no influence on frequency of refluxes. J Clin Anesth 2008 0.76
20 Laparoscopic mesh-augmented hiatoplasty as a treatment of gastroesophageal reflux disease and hiatal hernias-preliminary clinical and functional results of a prospective case series. Am J Surg 2008 0.76
21 Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma. Swiss Med Wkly 2003 0.75
22 Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study. Wien Med Wochenschr 2012 0.75
23 Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1. Am J Gastroenterol 2013 0.75
24 Long-Term Effiicacy and Safety of Certolizumab Pegol in an Unselected Crohn's Disease Population: The FACTS III Survey. Dig Dis 2017 0.75